â?? A clinical trial to study the effects of Virechana Karma, and Haridradi Avleha in the patient having symptomts of Tamaka Shwasa w.s.r to Bronchial Asthma. â??

â??Clinical Evaluation of Haridradi Avleha and Virechana Karma in the Management of Tamaka Shwasa w.s.r. to Bronchial Asthmaâ??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/12/010920

Enrollment

Registered

2017-12-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having symptoms of tamaka shwasa (Bronchial Asthma)

Interventions

Intervention1: Haridradi Avleha: Haridradi Avleha 20 gram twice a day orally before meal for 28 days. Control Intervention1: Virechana Karma: Virechana Karma with 2-3 tab (250 mg each tab) of Abhyadi

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing for trial and give consent. 2.Patients of age group 18 to 60 years of either sex. 3.Patients having signs and symptoms of Tamaka Shwasa (Bronchial asthma) as mentioned in Ayurvedic and Modern texts. 4.Patients fit for Virechana Karma.

Exclusion criteria

Exclusion criteria: 1.Patients not willing for trial. 2.Age below 18 and above 60years of either sex. 3.Patients suffering from Pulmonary Tuberculosis, Anaemia, Bronchus/Bronchogenic carcinoma, Chronic obstructive pulmonary disease, Pleural effusion. 4.Status asthmaticus. 5.Patients with rectal or vaginal prolapse. 6.Pregnant and lactating women. 7.Pateints suffering from serious systemic disorders like renal diseases, heart diseases, malignant hypertention, Diabetes Mellitus.Patients who are unfit for Virechana Karma.

Design outcomes

Primary

Measure	Time frame
Patients of both sexes between age group 18-60 of tamak shwasa will be selected for relieving signs and symptomsTimepoint: Patients of both sexes between age group 18-60 of tamak shwasa will be selected for relieving signs and symptoms	—

Secondary

Measure	Time frame
Assess the comparative efficacy between Haridradi Avleha and Virechana Karma after 4 weeks in case of Tamaka ShwasaTimepoint: Assess the comparative efficacy between Haridradi Avleha and Virechana Karma after 4 weeks in case of Tamaka Shwasa	—

Countries

India

Contacts

Public ContactDr Niharika Shakya

National Institute of Ayurveda

nshakya012@gmail.com9451582647

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026